Literature DB >> 28576916

Fabry heterozygote mimicking multiple sclerosis.

Wai Yan Yau1, Marzena J Fabis-Pedrini2, Allan G Kermode3.   

Abstract

Fabry's disease (FD) is a recognised mimic of multiple sclerosis (MS). It is an X-linked storage lysosomal disorder with deficiency of α-galactosidase A and enzyme replacement therapy is available. Patients with FD may satisfy modified McDonald criteria if the diagnosis of FD has not been pursued. We present a case of FD in a 65-year-old woman masquerading as benign MS for 40 years. She has recurrent posterior circulation stroke-like symptoms, hearing loss and acroparaesthesia, but typical radiological features of MS on MRI brain. Later she developed an ischaemic stroke, infiltrative cardiomyopathy and chronic renal failure. There was a missense mutation at p.R342Q in the galactodisdase alpha (GLA) gene. Neurologists need to consider FD and look for red flags in atypical MS cases and should not be over-reliant on MRI findings. Missed diagnosis of FD could lead to unnecessary immunosuppression, inappropriate disease counselling and missed treatment opportunity. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Multiple sclerosis; Neurogenetics; Neurology

Mesh:

Substances:

Year:  2017        PMID: 28576916      PMCID: PMC5534993          DOI: 10.1136/bcr-2017-220274

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life.

Authors:  Raymond Y Wang; Alicia Lelis; James Mirocha; William R Wilcox
Journal:  Genet Med       Date:  2007-01       Impact factor: 8.822

2.  Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

Authors:  C M Eng; N Guffon; W R Wilcox; D P Germain; P Lee; S Waldek; L Caplan; G E Linthorst; R J Desnick
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

Review 3.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

4.  CNS manifestations of Fabry's disease.

Authors:  Andreas Fellgiebel; Matthias J Müller; Lionel Ginsberg
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

5.  Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.

Authors:  M Ries; H J Kim; C K Zalewski; M A Mastroianni; D F Moore; R O Brady; J M Dambrosia; R Schiffmann; C C Brewer
Journal:  Brain       Date:  2006-11-14       Impact factor: 13.501

6.  D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinic.

Authors:  Jana Becker; Arndt Rolfs; Nesrin Karabul; Peter Berlit; Markus Kraemer
Journal:  Mult Scler       Date:  2016-03-18       Impact factor: 6.312

7.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

8.  Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?

Authors:  Tobias Böttcher; Arndt Rolfs; Christian Tanislav; Andreas Bitsch; Wolfgang Köhler; Jens Gaedeke; Anne-Katrin Giese; Edwin H Kolodny; Thomas Duning
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

  8 in total
  3 in total

Review 1.  Neuroimaging in Fabry disease: current knowledge and future directions.

Authors:  Sirio Cocozza; Camilla Russo; Giuseppe Pontillo; Antonio Pisani; Arturo Brunetti
Journal:  Insights Imaging       Date:  2018-11-02

2.  Stratification of patients with unclassified pain in the FabryScan database.

Authors:  Julia Forstenpointner; Paul Moeller; Manon Sendel; Maren Reimer; Philipp Hüllemann; Ralf Baron
Journal:  J Pain Res       Date:  2019-07-23       Impact factor: 3.133

3.  Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease.

Authors:  Jakob Rath; Olivia Foesleitner; Lukas Haider; Hubert Bickel; Fritz Leutmezer; Stephan Polanec; Michael A Arnoldner; Gere Sunder-Plassmann; Daniela Prayer; Thomas Berger; Paulus Rommer; Gregor Kasprian
Journal:  Orphanet J Rare Dis       Date:  2022-02-05       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.